
Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry
Description
Geopolitical, Macroeconomic, & Regulatory Changes Impacting the Pharmaceutical Industry
Summary
Within the first 100 days of the current US Administration, there have been a series of changes in the US that will impact the pharmaceutical industry.
To date, key outcomes have included -
Summary
Within the first 100 days of the current US Administration, there have been a series of changes in the US that will impact the pharmaceutical industry.
To date, key outcomes have included -
- Leadership changes across the Department of Health and Human Services (HHS)
- Major cuts across key departments and health programs
- Additional regulations that may curb investments
- Introduction of a reciprocal tariff framework
- Significant tariffs on strategic sectors such as steel, aluminum, and automotive and potential tariffs on pharmaceuticals
- Heightened tensions between the US and China
- This report examines the transition of the 47th U.S. Administration toward a protectionist trade policy during its first 100 days.
- The analysis focuses on efforts to reduce the trade deficit while assessing the broader implications for domestic industry and global trade relations.
Table of Contents
14 Pages
- Introduction
- Impact of Geopolitical Changes and Macroeconomics on Pharma
- Leadership: Key Departmental Changes Will Have Significant Impact on Pharma Industry and Patients
- Reduced Funding and Staff Cuts: ~10,000 Employees Fired Across Healthcare Departments and $250 Million in Cuts in NIH Funding
- New Regulations and Policies
- China Impact and Innovation Boost
- Tariffs
- Revitalization of the Biotech Industry to Support Innovation
- About GlobalData
- Contact us
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.